title: Xanthohumol inhibits growth and vascularization of developing endometriotic lesions.
abstract: BACKGROUND
  Xanthohumol is a prenylated flavonoid isolated from hops, which is known to act as a pleiotropic cancer chemopreventive agent owing to its anti-proliferative, anti-inflammatory and anti-angiogenic properties. In the present study, we analyzed, for the first time, whether this dietary compound may also be used for the treatment of endometriosis.
  
  
  METHODS
  Peritoneal and mesenteric endometriotic lesions were surgically induced in BALB/c mice by uterine tissue transplantation into the abdominal cavity. The animals were treated daily with 100 µM xanthohumol (n= 8) or vehicle (control, n= 8) via the drinking water, starting 3 days before tissue transplantations. Lesion growth, cyst formation and vascularization were subsequently analyzed by means of high-resolution ultrasound imaging (at Day 0 and then once per week for 28 days), caliper measurements, western blotting, histology and immunohistochemistry over 4 weeks.
  
  
  RESULTS
  In the treatment and control groups, uterine grafts developed typical endometriotic lesions with cyst-like dilated glands surrounded by a vascularized endometrial stroma. However, xanthohumol efficiently decreased the size of these lesions at Day 28, independent of their localization within the peritoneal cavity, compared with control (peritoneal: P =0.041; mesenteric: P =0.038). This was associated with a reduced level of phosphoinositide 3-kinase protein. Moreover, vascularization of xanthohumol-treated lesions was suppressed, as indicated by a significantly lower microvessel density at Day 28 when compared with vehicle-treated controls (peritoneal: P =0.026; mesenteric: P =0.004). Additional analyses revealed that treatment with xanthohumol did not affect the histomorphology, proliferation and vascularization of the uterine horns and ovaries.
  
  
  CONCLUSIONS
  Taken together, these experimental findings suggest that xanthohumol inhibits the development of endometriotic lesions in mice without inducing serious side effects in the reproductive organs. Thus, xanthohumol represents a promising dietary phytochemical that, after further testing, may be considered for the use in the selective treatment of endometriotic lesions.
authors.affiliation: Institute for Clinical & Experimental Surgery, University of Saarland, Saar, Germany. jeannette.rudzitis-auth@uks.eu
authors.forename: J
authors.initials: J
authors.lastname: Rudzitis-Auth
authors.forename: C
authors.initials: C
authors.lastname: Körbel
authors.forename: C
authors.initials: C
authors.lastname: Scheuer
authors.forename: M D
authors.initials: MD
authors.lastname: Menger
authors.forename: M W
authors.initials: MW
authors.lastname: Laschke
mesh_terms: D034841:Abdominal Cavity; D000818:Animals; D004032:Diet; D004715:Endometriosis / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D005260:Female; D005419:Flavonoids / Q000008:administration & dosage / Q000627:therapeutic use*; D027582:Humulus / Q000737:chemistry; D008643:Mesentery; D051379:Mice; D008807:Mice, Inbred BALB C; D009389:Neovascularization, Pathologic / Q000188:drug therapy; D010532:Peritoneal Diseases / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D008517:Phytotherapy; D011427:Propiophenones / Q000008:administration & dosage / Q000627:therapeutic use*; D014599:Uterus / Q000637:transplantation
chemical_list: D005419:Flavonoids; D011427:Propiophenones; C104536:xanthohumol